vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and GREENPOWER MOTOR Co INC. (GP). Click either name above to swap in a different company.

Arcellx, Inc. is the larger business by last-quarter revenue ($8.1M vs $7.2M, roughly 1.1× GREENPOWER MOTOR Co INC.). GREENPOWER MOTOR Co INC. runs the higher net margin — -65.6% vs -766.0%, a 700.4% gap on every dollar of revenue. On growth, GREENPOWER MOTOR Co INC. posted the faster year-over-year revenue change (-11.5% vs -79.3%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.

ACLX vs GP — Head-to-Head

Bigger by revenue
ACLX
ACLX
1.1× larger
ACLX
$8.1M
$7.2M
GP
Growing faster (revenue YoY)
GP
GP
+67.8% gap
GP
-11.5%
-79.3%
ACLX
Higher net margin
GP
GP
700.4% more per $
GP
-65.6%
-766.0%
ACLX

Income Statement — Q1 FY2025 vs Q3 FY2025

Metric
ACLX
ACLX
GP
GP
Revenue
$8.1M
$7.2M
Net Profit
$-62.3M
$-4.7M
Gross Margin
14.6%
Operating Margin
-847.6%
Net Margin
-766.0%
-65.6%
Revenue YoY
-79.3%
-11.5%
Net Profit YoY
-765.1%
-2.1%
EPS (diluted)
$-1.13
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
GP
GP
Q1 25
$8.1M
Q4 24
$15.3M
$7.2M
Q3 24
$26.0M
$5.3M
Q2 24
$27.4M
$3.0M
Q1 24
$39.3M
Q4 23
$63.1M
$8.2M
Q3 23
$15.0M
$8.4M
Q2 23
$14.3M
$17.6M
Net Profit
ACLX
ACLX
GP
GP
Q1 25
$-62.3M
Q4 24
$-47.1M
$-4.7M
Q3 24
$-25.9M
$-4.7M
Q2 24
$-27.2M
$-5.4M
Q1 24
$-7.2M
Q4 23
$19.8M
$-4.6M
Q3 23
$-39.3M
$-4.3M
Q2 23
$-23.9M
$-2.8M
Gross Margin
ACLX
ACLX
GP
GP
Q1 25
Q4 24
14.6%
Q3 24
8.6%
Q2 24
7.4%
Q1 24
Q4 23
16.6%
Q3 23
14.6%
Q2 23
15.9%
Operating Margin
ACLX
ACLX
GP
GP
Q1 25
-847.6%
Q4 24
-348.2%
Q3 24
-129.1%
Q2 24
-127.8%
Q1 24
-40.3%
Q4 23
23.8%
Q3 23
-299.9%
Q2 23
-206.7%
Net Margin
ACLX
ACLX
GP
GP
Q1 25
-766.0%
Q4 24
-308.4%
-65.6%
Q3 24
-99.4%
-87.9%
Q2 24
-99.3%
-179.8%
Q1 24
-18.3%
Q4 23
31.4%
-56.9%
Q3 23
-263.0%
-50.4%
Q2 23
-166.8%
-16.0%
EPS (diluted)
ACLX
ACLX
GP
GP
Q1 25
$-1.13
Q4 24
$-0.87
$-0.17
Q3 24
$-0.48
$-0.18
Q2 24
$-0.51
$-0.21
Q1 24
$-0.14
Q4 23
$0.42
$-0.19
Q3 23
$-0.81
$-0.17
Q2 23
$-0.50
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
GP
GP
Cash + ST InvestmentsLiquidity on hand
$543.3M
$621.1K
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$2.1M
Total Assets
$648.1M
$37.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
GP
GP
Q1 25
$543.3M
Q4 24
$587.4M
$621.1K
Q3 24
$574.3M
$116.9K
Q2 24
$516.7M
$528.3K
Q1 24
$573.9M
Q4 23
$702.0M
$4.0M
Q3 23
$439.7M
$2.0M
Q2 23
$506.5M
$1.5M
Stockholders' Equity
ACLX
ACLX
GP
GP
Q1 25
$416.9M
Q4 24
$454.8M
$2.1M
Q3 24
$483.0M
$4.2M
Q2 24
$487.2M
$8.6M
Q1 24
$496.6M
Q4 23
$485.4M
$18.1M
Q3 23
$266.1M
$22.3M
Q2 23
$293.7M
$26.2M
Total Assets
ACLX
ACLX
GP
GP
Q1 25
$648.1M
Q4 24
$711.3M
$37.4M
Q3 24
$764.9M
$39.4M
Q2 24
$734.3M
$43.5M
Q1 24
$779.7M
Q4 23
$825.1M
$50.2M
Q3 23
$614.2M
Q2 23
$623.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
GP
GP
Operating Cash FlowLast quarter
$-63.1M
$-1.1M
Free Cash FlowOCF − Capex
$-63.9M
FCF MarginFCF / Revenue
-786.4%
Capex IntensityCapex / Revenue
9.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
GP
GP
Q1 25
$-63.1M
Q4 24
$-46.0M
$-1.1M
Q3 24
$30.7M
$-1.3M
Q2 24
$-36.2M
$-3.2M
Q1 24
$-31.9M
Q4 23
$58.2M
$1.4M
Q3 23
$-10.1M
$-5.4M
Q2 23
$-22.6M
$7.8M
Free Cash Flow
ACLX
ACLX
GP
GP
Q1 25
$-63.9M
Q4 24
$-47.5M
Q3 24
$28.4M
Q2 24
$-39.5M
Q1 24
$-38.3M
Q4 23
$53.0M
Q3 23
$-18.0M
Q2 23
$-29.8M
FCF Margin
ACLX
ACLX
GP
GP
Q1 25
-786.4%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
Q1 24
-97.7%
Q4 23
83.9%
Q3 23
-120.5%
Q2 23
-208.7%
Capex Intensity
ACLX
ACLX
GP
GP
Q1 25
9.6%
Q4 24
9.8%
Q3 24
8.8%
Q2 24
11.7%
Q1 24
16.4%
Q4 23
8.4%
Q3 23
53.0%
Q2 23
50.5%
Cash Conversion
ACLX
ACLX
GP
GP
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
2.94×
Q3 23
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons